Zymeworks Inc. Common Shares (ZYME): Price and Financial Metrics
ZYME Price/Volume Stats
| Current price | $12.60 | 52-week high | $17.70 |
| Prev. close | $12.13 | 52-week low | $8.21 |
| Day low | $12.33 | Volume | 362,183 |
| Day high | $12.75 | Avg. volume | 558,068 |
| 50-day MA | $11.72 | Dividend yield | N/A |
| 200-day MA | $13.05 | Market Cap | 876.67M |
ZYME Stock Price Chart Interactive Chart >
Zymeworks Inc. Common Shares (ZYME) Company Bio
Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company was founded in 2003 and is based in Vancouver, BC.
ZYME Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ZYME Price Returns
| 1-mo | 11.11% |
| 3-mo | 5.00% |
| 6-mo | -11.58% |
| 1-year | 38.46% |
| 3-year | 86.67% |
| 5-year | -65.57% |
| YTD | -13.93% |
| 2024 | 40.90% |
| 2023 | 32.19% |
| 2022 | -52.04% |
| 2021 | -65.32% |
| 2020 | 3.96% |